"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board members said.

Activist investor Politan Capital secured two board seats at medical technology company Masimo, ousting founder and CEO Joe Kiani and director Chris Chavez. According to an anonymous source familiar with the situation,

Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a close, at least for now. Politan’s gains double the two board seats it claimed last year.

Masimo (NASDAQ:MASI) rose 3% after activist investor Politan Capital Management won two board seats after a bitter proxy battle with the medical device maker. Politan nominees  Darlene Solomon and William Jellison were elected to the board at a holder vote on Thursday,

Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles of the year.